<table frame="void" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col align="left" width="15%"></col>
<col align="left" width="50%"></col>
<tbody>
<tr>
<td align="left" colspan="3">I. Due to the competition of salicylate with other drugs for binding to serum albumin the following drug interactions may occur:<br/>
</td>
</tr>
<tr>
<th align="left">Drug</th>
<th align="left">Description of Interaction</th>
</tr>
<tr>
<td align="left">Tolbutamide; Sulfonylureas</td>
<td align="left">Hypoglycemia potentiated</td>
</tr>
<tr>
<td>Methotrexate</td>
<td>Decrease tubular reabsorption; clinical toxicity from methotrexate can result</td>
</tr>
<tr>
<td>Oral Anticoagulants</td>
<td>Increased bleeding</td>
</tr>
<tr>
<td align="left" colspan="3">
<br/>II. Drugs changing salicylate levels by altering renal tubular reabsorption:</td>
</tr>
<tr>
<th align="left">Drug</th>
<th align="left">Description of Interaction</th>
</tr>
<tr>
<td align="left">Corticosteroids</td>
<td align="left">Decreases plasma salicylate level; tapering doses of steroids may promote salicylism</td>
</tr>
<tr>
<td align="left">Ammonium Sulfate</td>
<td align="left">Increases plasma salicylate level</td>
</tr>
<tr>
<td align="left" colspan="3">
<br/>III. Drugs with complicated interactions with salicylates:</td>
</tr>
<tr>
<th align="left">Drug</th>
<th align="left">Description of Interaction</th>
</tr>
<tr>
<td align="left">Heparin</td>
<td align="left">Salicylate decreases platelet adhesivesness and interferes with hemostasis in heparin-treated patients</td>
</tr>
<tr>
<td align="left">Pyrazinamide</td>
<td align="left">Inhibits pyrazinamide-induced hyperuricemia</td>
</tr>
<tr>
<td align="left">Uricosuric Agents</td>
<td align="left">Effect of probenecid, sulfinpyrazone and phenylbutazone inhibited</td>
</tr>
<tr>
<td align="left" colspan="3">
<br/>The following alterations of laboratory tests have been reported during salicylate therapy<sup>6</sup>:</td>
</tr>
<tr>
<th align="left">Laboratory Tests</th>
<th align="left">Effect of Salicylates</th>
</tr>
<tr>
<td align="left">Thyroid Function</td>
<td align="left">Decreased PBI; increased T<sub>3</sub> uptake</td>
</tr>
<tr>
<td align="left">Urinary Sugar</td>
<td align="left">False negative with glucose oxidase; false positive with Clinitest with high-dose salicylate therapy (2 - 5 g qd)</td>
</tr>
<tr>
<td align="left">5 Hydroxyindole Acetic Acid</td>
<td align="left">False negative with fluorometric test</td>
</tr>
<tr>
<td align="left">Acetone, Ketone Bodies</td>
<td align="left">False positive FeCl<sub>3</sub> in Gerhardt reaction; red color persists with boiling</td>
</tr>
<tr>
<td align="left">17-OH Corticosteroids</td>
<td align="left">False reduced values with &gt;4.8 g qd salicylate</td>
</tr>
<tr>
<td align="left">Vanilmandelic Acid</td>
<td align="left">False reduced values</td>
</tr>
<tr>
<td align="left">Uric Acid</td>
<td align="left">May increase or decrease depending on dose</td>
</tr>
<tr>
<td align="left">Prothrombin</td>
<td align="left">Decreased levels; slightly increased prothrombin time</td>
</tr>
</tbody>
</table>